NASDAQ : BSEM
BioStem Technologies, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 1.12 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 20.81M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 20.81M |
| Enterprise Value | 15.08M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 18.58M |
| Shares Outstanding | 18.58M |
| Shares Change (YoY) | -26.89% |
| Shares Change (QoQ) | +2.83% |
| Owned by Insiders (%) | 23.63% |
| Owned by Institutions (%) | 3.05% |
| Float | 14.19M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.60 |
| Forward PS | 0.58 |
| PB Ratio | 0.72 |
| P/TBV Ratio | 4.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.98 |
| Quick Ratio | 0.64 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -74.74% |
| Return on Assets (ROA) | -18.07% |
| Return on Invested Capital (ROIC) | -107.74% |
| Return on Capital Employed (ROCE) | -84.50% |
| Weighted Average Cost of Capital (WACC) | 6.62% |
| Revenue Per Employee | $473,789 |
| Profits Per Employee | -$387,544 |
| Employee Count | 73 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.94 |
Taxes
| Measure | Value |
|---|
| Income Tax | 4.65M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -75.97% |
| 50-Day Moving Average | 3.08 |
| 200-Day Moving Average | 4.20 |
| Relative Strength Index (RSI) | 21.92 |
| Average Volume (20 Days) | 151,403 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 333,843 |
| Short Previous Month | 133,922 |
| Short % of Shares Out | 1.80% |
| Short % of Float | 2.35% |
| Short Ratio (days to cover) | 2.00 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 34.59M |
| Gross Profit | 27.65M |
| Operating Income | -23.34M |
| Pretax Income | -23.64M |
| Net Income | -28.29M |
| EBITDA | -22.00M |
| EBIT | -23.34M |
| Loss Per Share | -$1.67 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 6.96M |
| Total Debt | 1.22M |
| Net Cash | 5.74M |
| Net Cash Per Share | $0.31 |
| Equity (Book Value) | 27.61M |
| Book Value Per Share | 1.55 |
| Working Capital | -421,290 |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -5.92M |
| Capital Expenditures | -2.91M |
| Depreciation & Amortization | 1.33M |
| Net Borrowing | -3.65M |
| Free Cash Flow | -8.83M |
| FCF Per Share | -$0.48 |
Margins
| Measure | Value |
|---|
| Gross Margin | 79.94% |
| Operating Margin | -67.47% |
| Pretax Margin | -68.35% |
| Profit Margin | -81.80% |
| EBITDA Margin | -63.61% |
| EBIT Margin | -67.47% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 26.89% |
| Shareholder Yield | 26.89% |
| Earnings Yield | -149.23% |
| FCF Yield | -42.43% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 21.31% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 27, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:400 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.78 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |